ID CLB HC.PH.BIO.CLB
Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.
Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.
Companies whose primary class this is. The sector and industry pages and the screener count them the same way.
| Company | Ticker | Country | Market cap | Filings |
|---|---|---|---|---|
| ABION Inc. | 203400 | South Korea | — | 773 |
| KANGSTEM BIOTECH CO., LTD. | 217730 | South Korea | — | 768 |
| Medicofarma Biotech Spolka Akcyjna | MDB | Poland | — | 766 |
| ADALTA LIMITED | 1AD | Australia | — | 761 |
| Alteogen Inc. | 196170 | South Korea | — | 750 |
| Medicenna Therapeutics Corp. | MDNA | Canada | — | 746 |
| PARADIGM BIOPHARMACEUTICALS LIMITED.. | PAR | Australia | — | 741 |
| Onxeo | ALONX | France | — | 735 |
| RECCE PHARMACEUTICALS LTD | RCE | Australia | — | 731 |
| LigaChem Biosciences Inc. | 141080 | South Korea | — | 714 |
| RIBOMIC Inc. | 4591 | Japan | — | 700 |
| NEUROTECH INTERNATIONAL LIMITED | NTI | Australia | — | 695 |
| AMPLIA THERAPEUTICS LIMITED | ATX | Australia | — | 693 |
| Chiome Bioscience Inc. | 4583 | Japan | — | 693 |
| SillaJen, Inc. | 215600 | South Korea | — | 678 |
| DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. | 688192 | China | — | 667 |
| BetterLife Pharma | BETR | Canada | — | 666 |
| EyeGene,Inc | 185490 | South Korea | — | 666 |
| OLIPASS CORPORATION | 244460 | South Korea | — | 662 |
| ToolGen Incorporated | 199800 | South Korea | — | 661 |
| Aptahem AB | APTA | Sweden | — | 649 |
| Double Bond Pharmaceutical International AB | DBP B | Sweden | — | 647 |
| Mezzion Pharma Co., Ltd. | 140410 | South Korea | — | 638 |
| Devonian Health Group Inc | GSD | Canada | — | 617 |
| Kidswell Bio Corporation | 4584 | Japan | — | 612 |
| Transgene Biotek Ltd. | 526139 | India | — | 612 |
| Scorpius Holdings, Inc. | HTBX | United States of America | — | 610 |
| 康乐卫士 | 920575 | China | — | 594 |
| Hemostemix Inc. | HEM | Canada | — | 592 |
| Modalis Therapeutics Corporation | 4883 | Japan | — | 592 |
| FutureChem Co., Ltd. | 220100 | South Korea | — | 589 |
| SICHUAN BIOKIN PHARMACEUTICAL CO., LTD. | 688506 | China | — | 586 |
| Lin BioScience, Inc. | 6696 | Taiwan | — | 580 |
| Hepion Pharmaceuticals Inc | HEPA | United States of America | — | 570 |
| SAMSRITA LABS LIMITED | 539267 | India | — | 570 |
| Simris Group AB | SIMRIS | Sweden | — | 568 |
| Eutilex Co.,Ltd. | 263050 | South Korea | — | 566 |
| OliX Pharmaceuticals, Inc. | 226950 | South Korea | — | 564 |
| CHIMERIC THERAPEUTICS LIMITED | CHM | Australia | — | 561 |
| Core One Labs Inc. | COOL | Canada | — | 560 |
| Genome&Company | 314130 | South Korea | — | 559 |
| Kringle Pharma,Inc. | 4884 | Japan | — | 559 |
| Alar Pharmaceuticals Inc. | 6785 | Taiwan | — | 558 |
| Resverlogix Corp. | RVX | Canada | — | 555 |
| SCM Lifescience Co., Ltd. | 298060 | South Korea | — | 539 |
| NEXALIS THERAPEUTICS LTD | NX1 | Australia | — | 535 |
| StemRIM Inc. | 4599 | Japan | — | 535 |
| CAMBIUM BIO LIMITED | CMB | Australia | — | 531 |
| NervGen Pharma Corp. | NGEN | Canada | — | 530 |
| BioArctic | BIOA | Sweden | — | 528 |
Other names for this activity, and where neighboring activities go instead.
preclinicaldrug developer
Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.
https://financialfilings.com/oics/CLB/
This page is keyed by the class ID CLB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.
Sign in or create a free account - no password needed.
By continuing, you agree to our Terms and Privacy Policy.